220 related articles for article (PubMed ID: 18428067)
21. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies.
Verdejo-García A; Lawrence AJ; Clark L
Neurosci Biobehav Rev; 2008; 32(4):777-810. PubMed ID: 18295884
[TBL] [Abstract][Full Text] [Related]
22. The orbitofrontal cortex, impulsivity, and addiction: probing orbitofrontal dysfunction at the neural, neurochemical, and molecular level.
Winstanley CA
Ann N Y Acad Sci; 2007 Dec; 1121():639-55. PubMed ID: 17846162
[TBL] [Abstract][Full Text] [Related]
23. Cognitive remediation in the treatment of stimulant abuse disorders: a research agenda.
Vocci FJ
Exp Clin Psychopharmacol; 2008 Dec; 16(6):484-97. PubMed ID: 19086769
[TBL] [Abstract][Full Text] [Related]
24. [Psychobiologic risk factors and vulnerability to psychostimulants in adolescents and animal models].
Laviola G; Adriani W; Terranova ML; Gerra G
Ann Ist Super Sanita; 2000; 36(1):47-62. PubMed ID: 11070608
[TBL] [Abstract][Full Text] [Related]
25. The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review.
Ortal S; van de Glind G; Johan F; Itai B; Nir Y; Iliyan I; van den Brink W
Curr Drug Abuse Rev; 2015; 8(2):119-33. PubMed ID: 26373850
[TBL] [Abstract][Full Text] [Related]
26. An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional survey.
Reece AS
Br Dent J; 2008 Dec; 205(11):E22. PubMed ID: 18953330
[TBL] [Abstract][Full Text] [Related]
27. Social dominance mediates the association of testosterone and neurobehavioral disinhibition with risk for substance use disorder.
Tarter RE; Kirisci L; Kirillova GP; Gavaler J; Giancola P; Vanyukov MM
Psychol Addict Behav; 2007 Dec; 21(4):462-8. PubMed ID: 18072828
[TBL] [Abstract][Full Text] [Related]
28. Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention.
Yücel M; Lubman DI
Drug Alcohol Rev; 2007 Jan; 26(1):33-9. PubMed ID: 17364834
[TBL] [Abstract][Full Text] [Related]
29. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.
Reif A; Jacob CP; Rujescu D; Herterich S; Lang S; Gutknecht L; Baehne CG; Strobel A; Freitag CM; Giegling I; Romanos M; Hartmann A; Rösler M; Renner TJ; Fallgatter AJ; Retz W; Ehlis AC; Lesch KP
Arch Gen Psychiatry; 2009 Jan; 66(1):41-50. PubMed ID: 19124687
[TBL] [Abstract][Full Text] [Related]
30. The role of impulsivity in the development of substance use and eating disorders.
Dawe S; Loxton NJ
Neurosci Biobehav Rev; 2004 May; 28(3):343-51. PubMed ID: 15225976
[TBL] [Abstract][Full Text] [Related]
31. [Adolescence, schizophrenia and drug abuse: interactive vulnerability. A hypothesis].
van Nimwegen L; de Haan L; van Beveren N; van den Brink W; Linszen D
Tijdschr Psychiatr; 2007; 49(3):169-78. PubMed ID: 17370223
[TBL] [Abstract][Full Text] [Related]
32. Brain activation, response inhibition, and increased risk for substance use disorder.
McNamee RL; Dunfee KL; Luna B; Clark DB; Eddy WF; Tarter RE
Alcohol Clin Exp Res; 2008 Mar; 32(3):405-13. PubMed ID: 18302723
[TBL] [Abstract][Full Text] [Related]
33. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments.
Karterud S; Arefjord N; Andresen NE; Pedersen G
Nord J Psychiatry; 2009; 63(1):57-63. PubMed ID: 19172500
[TBL] [Abstract][Full Text] [Related]
34. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
35. Empathy dysfunction in children and adolescents with disruptive behavior disorders.
de Wied M; Gispen-de Wied C; van Boxtel A
Eur J Pharmacol; 2010 Jan; 626(1):97-103. PubMed ID: 19836371
[TBL] [Abstract][Full Text] [Related]
36. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.
Kreek MJ; Nielsen DA; Butelman ER; LaForge KS
Nat Neurosci; 2005 Nov; 8(11):1450-7. PubMed ID: 16251987
[TBL] [Abstract][Full Text] [Related]
37. Early childhood predictors of early substance use and substance use disorders: prospective study.
Hayatbakhsh MR; Mamun AA; Najman JM; O'Callaghan MJ; Bor W; Alati R
Aust N Z J Psychiatry; 2008 Aug; 42(8):720-31. PubMed ID: 18622780
[TBL] [Abstract][Full Text] [Related]
38. Childhood predictors of completed and severe suicide attempts: findings from the Finnish 1981 Birth Cohort Study.
Sourander A; Klomek AB; Niemelä S; Haavisto A; Gyllenberg D; Helenius H; Sillanmäki L; Ristkari T; Kumpulainen K; Tamminen T; Moilanen I; Piha J; Almqvist F; Gould MS
Arch Gen Psychiatry; 2009 Apr; 66(4):398-406. PubMed ID: 19349309
[TBL] [Abstract][Full Text] [Related]
39. [ADHD and attachment processes: are they related?].
Franc N; Maury M; Purper-Ouakil D
Encephale; 2009 Jun; 35(3):256-61. PubMed ID: 19540412
[TBL] [Abstract][Full Text] [Related]
40. Prevalence, timing, and predictors of transitions from inhalant use to inhalant use disorders.
Perron BE; Howard MO; Maitra S; Vaughn MG
Drug Alcohol Depend; 2009 Mar; 100(3):277-84. PubMed ID: 19091490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
